A. Dori, M. Guglieri, M. Scutifero, L. Passamano, L. Trabacca, and L. Politano, “Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up”, Acta Myol, vol. 41, no. 1, Mar. 2022.